SCHEMBL13609529

SCHEMBL13609529

CCOC(=O)C(=O)c1ccc(SC2CC2)c(F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.37
MAPT P10636 6/20 0.36
RAB9A P51151 1/20 0.36
HPGD P15428 2/20 0.36
ALDH1A1 P00352 5/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
CHRM1 P11229 2/20 0.35
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
HTT P42858 1/20 0.34
ATM Q13315 1/20 0.34
LMNA P02545 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
NPC1 O15118 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
HSD17B10 Q99714 1/20 0.34
PDE4B Q07343 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4260216 0.87 HTT (0.39) L3MBTL1MAPTRAB9AHPGDALDH1A1
SCHEMBL13033252 0.86 ALDH1A1 (0.38) L3MBTL1MAPTRAB9AHPGDALDH1A1
SCHEMBL2655589 0.85 TSHR (0.41) L3MBTL1MAPTRAB9AHPGDALDH1A1
SCHEMBL12982926 0.82 CES2 (0.40) L3MBTL1MAPTHPGDALDH1A1MEN1
SCHEMBL13609530 0.82 PDE4B (0.38) L3MBTL1MAPTRAB9AHPGDALDH1A1
SCHEMBL1864074 0.80 TAS1R3 (0.42) MAPTRAB9AHPGDALDH1A1MEN1
SCHEMBL185319 0.78 ALDH1A1 (0.42) L3MBTL1MAPTRAB9AHPGDALDH1A1
SCHEMBL3184223 0.77 CES2 (0.60) L3MBTL1MAPTRAB9AHPGDALDH1A1
SCHEMBL11232893 0.74 ALOX5AP (0.39) L3MBTL1MAPTRAB9AHPGDALDH1A1
SCHEMBL17420534 0.74 CES2 (0.42) L3MBTL1MAPTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090281142-A1 THIAZOLE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2009-11-12 US disclosed
EP-1921074-A1 THIAZOLE DERIVATIVE Astellas Pharma Inc. (JP) 2008-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090281142-A1 THIAZOLE DERIVATIVE GK, GCKR, AK2 L3MBTL1 2114/4885MAPT 4529/4885RAB9A 2687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.